Article Information
History
- April 26, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Mi Ni Huang1,2,
- Willie Yu1,2,
- Wei Wei Teoh3,
- Maude Ardin4,
- Apinya Jusakul1,5,
- Alvin Ng2,6,
- Arnoud Boot1,2,
- Behnoush Abedi-Ardekani7,
- Stephanie Villar4,
- Swe Swe Myint5,
- Rashidah Othman3,
- Song Ling Poon1,5,
- Adriana Heguy8,
- Magali Olivier4,
- Monica Hollstein4,
- Patrick Tan1,
- Bin Tean Teh1,5,
- Kanaga Sabapathy1,3,
- Jiri Zavadil4 and
- Steven G. Rozen1,2
- 1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, 169857, Singapore
- 2Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, 169857, Singapore
- 3Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
- 4Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, Lyon, France
- 5Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
- 6NUS Graduate School for Integrative Sciences and Engineering, 28 Medical Drive, 117456, Singapore
- 7Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France
- 8Department of Pathology and Genome Technology Center, New York University Langone Medical Center, New York, NY 10016, United States of America
- Correspondence: Kanaga Sabapathy, cmrksb{at}nccs.com.sg, Jiri Zavadil, zavadilj{at}iarc.fr, Steven G. Rozen, steve.rozen{at}duke-nus.edu.sg